BACKGROUND: Intraoperative parathyroid hormone (IOPTH) helps shorten the duration of surgery and increase the likelihood of surgical cure. Although general consensus agrees that the IOPTH should fall by 50%, there is much debate as to whether the IOPTH needs to fall into the normal range. METHODS: We retrospectively reviewed a prospective database of patients undergoing surgery for treatment of primary hyperparathyroidism. We included all patients with an IOPTH that fell by >50% by 10 or 15 min, but that did not fall into the normal range (parathyroid hormone remained ≥ 60 pg/ml). We excluded patients who had undergone prior neck surgery or had known multiple endocrine neoplasia 1 or 2. RESULTS: A total of 1,231 patients underwent a parathyroidectomy, 155 of whom met the study's inclusion/exclusion criteria (12.6%). A total of 117 patients had an IOPTH fall by 50% by 10 min, and 38 patients' IOPTH fell by 50% by 15 min. Overall surgical cure rate was 98.7%. One patient from the 10-minute group and one patient from the 15-minute group had persistent disease on follow-up. One patient in the 15-minute group had recurrent disease. With a mean ± SEM 18.1 ± 2.1 months' follow-up, the recurrence rate in this cohort was 0.6%. The average calcium at last follow-up was 9.4 ± 0.0 mg/dl. CONCLUSIONS: Allowing the IOPTH to fall by 50% by 15 min, regardless of whether the IOPTH falls into the normal range, results in a high success rate when performed by experienced surgeons. This helps reduce intraoperative time used waiting for additional parathyroid hormone levels and the risks associated with unnecessary bilateral neck exploration.
BACKGROUND: Intraoperative parathyroid hormone (IOPTH) helps shorten the duration of surgery and increase the likelihood of surgical cure. Although general consensus agrees that the IOPTH should fall by 50%, there is much debate as to whether the IOPTH needs to fall into the normal range. METHODS: We retrospectively reviewed a prospective database of patients undergoing surgery for treatment of primary hyperparathyroidism. We included all patients with an IOPTH that fell by >50% by 10 or 15 min, but that did not fall into the normal range (parathyroid hormone remained ≥ 60 pg/ml). We excluded patients who had undergone prior neck surgery or had known multiple endocrine neoplasia 1 or 2. RESULTS: A total of 1,231 patients underwent a parathyroidectomy, 155 of whom met the study's inclusion/exclusion criteria (12.6%). A total of 117 patients had an IOPTH fall by 50% by 10 min, and 38 patients' IOPTH fell by 50% by 15 min. Overall surgical cure rate was 98.7%. One patient from the 10-minute group and one patient from the 15-minute group had persistent disease on follow-up. One patient in the 15-minute group had recurrent disease. With a mean ± SEM 18.1 ± 2.1 months' follow-up, the recurrence rate in this cohort was 0.6%. The average calcium at last follow-up was 9.4 ± 0.0 mg/dl. CONCLUSIONS: Allowing the IOPTH to fall by 50% by 15 min, regardless of whether the IOPTH falls into the normal range, results in a high success rate when performed by experienced surgeons. This helps reduce intraoperative time used waiting for additional parathyroid hormone levels and the risks associated with unnecessary bilateral neck exploration.
Authors: Kelly L McCoy; Naomi H Chen; Michaele J Armstrong; Gina M Howell; Michael T Stang; Linwah Yip; Sally E Carty Journal: World J Surg Date: 2014-06 Impact factor: 3.352
Authors: Laura I Wharry; Linwah Yip; Michaele J Armstrong; Mohamed A Virji; Michael T Stang; Sally E Carty; Kelly L McCoy Journal: World J Surg Date: 2014-03 Impact factor: 3.352
Authors: Philipp Riss; Christoph Krall; Christian Scheuba; Christian Bieglmayer; Bruno Niederle Journal: Langenbecks Arch Surg Date: 2013-07-05 Impact factor: 3.445
Authors: G Conzo; A Perna; N Avenia; R M De Santo; C Della Pietra; A Palazzo; A A Sinisi; F Stanzione; L Santini Journal: Endocrine Date: 2012-03-16 Impact factor: 3.633
Authors: Yufei Chen; Carrie C Lubitz; Scott A Shikora; Richard A Hodin; Randall D Gaz; Francis D Moore; Travis J McKenzie Journal: Obes Surg Date: 2015-04 Impact factor: 4.129
Authors: Mohammad H Rajaei; Sarah C Oltmann; David F Schneider; Rebecca S Sippel; Herbert Chen Journal: Ann Surg Oncol Date: 2014-09-23 Impact factor: 5.344
Authors: David F Schneider; Kristin A Ojomo; Haggi Mazeh; Sarah C Oltmann; Rebecca S Sippel; Herbert Chen Journal: J Surg Res Date: 2013-05-03 Impact factor: 2.192
Authors: Mohammad H Rajaei; Alex M Bentz; David F Schneider; Rebecca S Sippel; Herbert Chen; Sarah C Oltmann Journal: Ann Surg Oncol Date: 2014-09-06 Impact factor: 5.344